TY - JOUR
T1 - Alcohol, Smoking, and Their Synergy as Risk Factors for Incident Type 2 Diabetes
AU - Paz-Graniel, Indira
AU - Kose, Junko
AU - Duquenne, Pauline
AU - Babio, Nancy
AU - Salas-Salvadó, Jordi
AU - Hercberg, Serge
AU - Galan, Pilar
AU - Touvier, Mathilde
AU - Fezeu, Léopold K.
AU - Andreeva, Valentina A.
N1 - Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
PY - 2025/11
Y1 - 2025/11
N2 - Introduction: Smoking has been independently related to an increased risk of Type 2 diabetes, whereas the role of alcohol remains controversial. The joint impact of tobacco and alcohol use on Type 2 diabetes risk is understudied. This study investigated individual and combined effects of smoking and alcohol on Type 2 diabetes risk. Methods: Data from 110,076 participants in the NutriNet-Santé cohort (2009–2023), who were free from Type 2 diabetes at baseline and with alcohol and smoking data, were analyzed. Multivariable Cox regression models assessed the association of alcohol consumption (<2 vs ≥2 portions/day, <10 vs ≥10 portions/week, grams/day of ethanol) and smoking (never versus former/current smoking) with Type 2 diabetes risk. Combined effects of heavy smoking (≥20 cigarettes/day) and heavy drinking (>8 and >15 portions/week for women and men, respectively) were also evaluated. Results: Over 7.5 years of follow-up (820,470 person-years), 1,175 Type 2 diabetes cases were identified. Alcohol consumption, including heavy intake, was not significantly associated with Type 2 diabetes risk. People who formerly or currently smoke had a 36% higher risk of Type 2 diabetes than people who have never smoked (hazard ratio=1.36; 95% CI=1.20, 1.53). Those who smoked heavily had over twice the risk of those who smoked lightly or moderately (hazard ratio=2.10; 95% CI=1.46, 3.02). Combined exposure to smoking and heavy alcohol use did not significantly increase Type 2 diabetes risk (hazard ratio=1.11; 95% CI=0.95, 1.29). Conclusions: These findings support smoking as an independent risk factor for Type 2 diabetes and show that alcohol consumption did not confer protection. The combined effect of alcohol and tobacco use on Type 2 diabetes risk and the mechanisms behind this relationship should be further explored. Trial registration: This trial is registered at NCT03335644 at ClinicalTrials.gov.
AB - Introduction: Smoking has been independently related to an increased risk of Type 2 diabetes, whereas the role of alcohol remains controversial. The joint impact of tobacco and alcohol use on Type 2 diabetes risk is understudied. This study investigated individual and combined effects of smoking and alcohol on Type 2 diabetes risk. Methods: Data from 110,076 participants in the NutriNet-Santé cohort (2009–2023), who were free from Type 2 diabetes at baseline and with alcohol and smoking data, were analyzed. Multivariable Cox regression models assessed the association of alcohol consumption (<2 vs ≥2 portions/day, <10 vs ≥10 portions/week, grams/day of ethanol) and smoking (never versus former/current smoking) with Type 2 diabetes risk. Combined effects of heavy smoking (≥20 cigarettes/day) and heavy drinking (>8 and >15 portions/week for women and men, respectively) were also evaluated. Results: Over 7.5 years of follow-up (820,470 person-years), 1,175 Type 2 diabetes cases were identified. Alcohol consumption, including heavy intake, was not significantly associated with Type 2 diabetes risk. People who formerly or currently smoke had a 36% higher risk of Type 2 diabetes than people who have never smoked (hazard ratio=1.36; 95% CI=1.20, 1.53). Those who smoked heavily had over twice the risk of those who smoked lightly or moderately (hazard ratio=2.10; 95% CI=1.46, 3.02). Combined exposure to smoking and heavy alcohol use did not significantly increase Type 2 diabetes risk (hazard ratio=1.11; 95% CI=0.95, 1.29). Conclusions: These findings support smoking as an independent risk factor for Type 2 diabetes and show that alcohol consumption did not confer protection. The combined effect of alcohol and tobacco use on Type 2 diabetes risk and the mechanisms behind this relationship should be further explored. Trial registration: This trial is registered at NCT03335644 at ClinicalTrials.gov.
UR - https://www.scopus.com/pages/publications/105013870724
U2 - 10.1016/j.amepre.2025.108011
DO - 10.1016/j.amepre.2025.108011
M3 - Article
C2 - 40752888
AN - SCOPUS:105013870724
SN - 0749-3797
VL - 69
JO - American Journal of Preventive Medicine
JF - American Journal of Preventive Medicine
IS - 5
M1 - 108011
ER -